Evaluation of blood TMB (bTMB) in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) with pemetrexed and platinum versus placebo plus chemo as first-line therapy for metastatic nonsquamous NSCLC.

被引：0
|
作者：
Chiara Garassino, Marina
Gadgeel, Shirish M.
Rodriguez-Abreu, Delvys
Felip, Enriqueta
Esteban, Emilio
Speranza, Giovanna
Hochmair, Maximilian
Francis Powell, Steven
Garon, Edward B.
Hui, Rina
Nogami, Naoyuki
Cristescu, Razvan
Morrissey, Michael
Loboda, Andrey
Kobie, Julie
Ayers, Mark
Piperdi, Bilal
Catherine Pietanza, Maria
Snyder, Alexandra
Reck, Martin
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[2] Karmanos Canc Inst, Detroit, MI USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Univ Las Palmas Gran Canaria, Complejo Hosp Univ Insular Maternoinfantil Gran C, Las Palmas Gran Canaria, Spain
[5] Hosp Univ Vall dHebron, Barcelona, Spain
[6] Hosp Univ Cent Asturias, Oviedo, Spain
[7] Univ Sherbrooke, Ctr Integre Cancerol Monteregie, Greenfield Pk, PQ, Canada
[8] Otto Wagner Hosp, Vienna, Austria
[9] Sanford Hlth, Sioux Falls, SD USA
[10] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[11] Westmead Hosp, Sydney, NSW, Australia
[12] Univ Sydney, Sydney, NSW, Australia
[13] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[14] Merck & Co Inc, Kenilworth, NJ USA
[15] German Ctr Lung Res, Airway Res Ctr North, LungenClin, Grosshansdorf, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9521
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Health-Related Quality of Life (HRQoL) with Pembrolizumab or Placebo plus Pemetrexed plus Platinum in Patients with Metastatic Non-Squamous NSCLC: Keynote-189
    Hui, R.
    Garassino, M. C.
    Rodriguez-Abreu, D.
    Gadgeel, S.
    Esteban, E.
    Felip, E.
    Speranza, G.
    Domine, M.
    Hochmair, M. J.
    Powell, S.
    Cheng, S. Y-S
    Bischoff, H. G.
    Peled, N.
    Reck, M.
    Garon, E. B.
    Boyer, M.
    Yang, J.
    Burke, T.
    Pietanza, M. C.
    Gandhi, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 47 - 47
  • [22] Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) in NSCLC with brain metastases: Pooled analysis of KEYNOTE-021, 189, and 407
    Powell, S. F.
    Rodriguez Abreu, D.
    Langer, C. J.
    Tafreshi, A.
    Paz-Ares, L.
    Kopp, H-G.
    Rodriguez-Cid, J.
    Kowalski, D.
    Cheng, Y.
    Kurata, T.
    Awad, M. M.
    Lin, J.
    Zhao, B.
    Pietanza, M. C.
    Piperdi, B.
    Garassino, M. C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] Association of TMB and PD-L1 with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (chemo) versus chemo in patients (pts) with advanced urothelial carcinoma (UC) from KEYNOTE-361.
    Morales-Barrera, Rafael
    Powles, Thomas
    Ozguroglu, Mustafa
    Csoszi, Tibor
    Loriot, Yohann
    Flechon, Aude
    Matsubara, Nobuaki
    Rodriguez-Vida, Alejo
    Geczi, Lajos
    Cheng, Susanna Y.
    Fradet, Yves
    Oudard, Stephane
    Gunduz, Seyda
    Ma, Junshui
    Rajasagi, Mohini
    Vajdi, Amir
    Cristescu, Razvan
    Imai, Kentaro
    Moreno, Blanca Homet
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [24] Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062
    Wyrwicz, L. S.
    Lee, K-W.
    Van Cutsem, E.
    Bang, Y-J.
    Fuchs, C. S.
    Kudaba, I.
    Garrido, M.
    Chung, H. C.
    Lee, J.
    Castro, H. R.
    Chao, J.
    Wainberg, Z. A.
    Cao, Z. A.
    Aurora-Garg, D.
    Kobie, J.
    Cristescu, R.
    Bhagia, P.
    Shah, S.
    Tabernero, J.
    Shitara, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S907 - S908
  • [25] Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study
    Horinouchi, Hidehito
    Nogami, Naoyuki
    Saka, Hideo
    Nishio, Makoto
    Tokito, Takaaki
    Takahashi, Toshiaki
    Kasahara, Kazuo
    Hattori, Yoshihiro
    Ichihara, Eiki
    Adachi, Noriaki
    Noguchi, Kazuo
    Souza, Fabricio
    Kurata, Takayasu
    CANCER SCIENCE, 2021, 112 (08) : 3255 - 3265
  • [26] Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
    Gadgeel, Shirish
    Rodriguez-Abreu, Delvys
    Speranza, Giovanna
    Esteban, Emilio
    Felip, Enriqueta
    Domine, Manuel
    Hui, Rina
    Hochmair, Maximilian J.
    Clingan, Philip
    Powell, Steven F.
    Cheng, Susanna Yee-Shan
    Bischoff, Helge G.
    Peled, Nir
    Grossi, Francesco
    Jennens, Ross R.
    Reck, Martin
    Garon, Edward B.
    Novello, Silvia
    Rubio-Viqueira, Belen
    Boyer, Michael
    Kurata, Takayasu
    Gray, Jhanelle E.
    Yang, Jing
    Bas, Tuba
    Pietanza, M. Catherine
    Garassino, Marina C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (14) : 1505 - +
  • [27] Pembrolizumab plus Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189
    Gray, J.
    Rodriguez-Abreu, D.
    Powell, S. F.
    Hochmair, M. J.
    Gadgeel, S.
    Esteban, E.
    Felip, E.
    Speranza, G.
    De Angelis, F.
    Domine, M.
    Cheng, S. Y.
    Bischoff, H. G.
    Peled, N.
    Reck, M.
    Hui, R.
    Garon, E. B.
    Boyer, M.
    Kurata, T.
    Yang, J.
    Jensen, E.
    Souza, F.
    Garassino, M. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S224 - S224
  • [28] Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189
    Garon, Edward B.
    Aerts, Joachim
    Kim, Jong Seok
    Muehlenbein, Catherine E.
    Peterson, Patrick
    Rizzo, Maria Teresa
    Gadgeel, Shirish M.
    LUNG CANCER, 2021, 155 : 53 - 60
  • [29] First-line lenvatinib (Len) plus pembrolizumab (Pembro) plus chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in
    Shitara, K.
    Ben-Aharon, I.
    Rojas, C.
    Eyzaguirre, D. A. Acosta
    Hubert, A.
    Moya, H. Araya
    Cohen, D.
    Bai, L-Y.
    Ghiringhelli, F.
    Wyrwicz, L.
    Janjigian, Y. Y.
    Tabernero, J.
    Van Cutsem, E.
    Qin, S.
    Xu, J.
    Wang, A.
    Miller, M. G.
    Shih, C-S.
    Bhagia, P.
    Weber, P. E. Yanez
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1108 - S1108
  • [30] Pemetrexed-Carboplatin Plus Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC: KEYNOTE-021 Cohort G Update
    Borghaei, H.
    Langer, C.
    Gadgeel, S.
    Papadimitrakopoulou, V.
    Patnaik, A.
    Powell, S.
    Gentzler, R.
    Martins, R.
    Stevenson, J.
    Jalal, S.
    Panwalkar, A.
    Yang, J. C.
    Gubens, M.
    Sequist, L.
    Awad, M.
    Fiore, J.
    Saraf, S.
    Raftopoulos, H.
    Gandhi, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1791 - S1791
12345